Figure 3From: Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world settingChange in status of OCS therapy in patients receiving maintenance OCS at baseline (n = 246; ITT population). n = Number of evaluable patients at each time-point. OCS, oral corticosteroids; ITT, intent-to-treat. Post-baseline data include doses of zero for patients no longer receiving OCS. Data at each time-point are relative to baseline.Back to article page